DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the SANOFI CONS HEALTHC IND L (SANOFICONR) share price today?

SANOFI CONS HEALTHC IND L (SANOFICONR) is trading at ₹4,567.2 on the NSE, up 0.19% on the day. Source: DocStoX.

What is the PE ratio of SANOFI CONS HEALTHC IND L?

SANOFI CONS HEALTHC IND L has a price-to-earnings (PE) ratio of 43.8 in the Healthcare sector.

What is the market capitalisation of SANOFI CONS HEALTHC IND L?

SANOFI CONS HEALTHC IND L has a market capitalisation of approximately ₹10,514 crore.

SANOFI CONS HEALTHC IND L

SANOFICONR·NSE·Healthcare

₹4,567.20▲ +8.70 (+0.19%)

Healthcare · Pharmaceuticals

Debt-free and consistently profitable

Day₹4516.00

₹4595.40

52W₹3915

₹551241%

Open

₹4558.50

High

₹4595.40

Low

₹4516.00

Prev Close

₹4558.50

Volume

2.2K

VWAP

₹4560.89

Snapshot

Key fundamentals

Market Cap

₹10,514 Cr

P/E Ratio

43.81Expensive

P/B Ratio

27.04

EPS

₹104.25

Book Value

₹167.00

ROE

71.60%Strong

ROCE

90.00%Efficient

Dividend Yield

1.66%

Debt / Equity

0.07Low

Face Value

₹10.00

52W High

₹5512.00

52W Low

₹3914.76

Sector

Healthcare

Industry

Pharmaceuticals

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹584

▼ 87.2%downside

Trading at ₹4,567 — 87% above our estimate

BearFair valueBull

₹496₹584₹671

/100

Business quality — Solid

Growth 35Profitability 100Efficiency 50Valuation 56

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet
Fundamental red flags (Piotroski 1/9)

Strengths

Virtually debt-free balance sheet
Strong returns on equity (72%)
Capital is working hard (ROCE 90%)
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

63% ROE fading to 12% over ~10 yrs, on ₹167 book

₹572

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹626

Analyst target

No analyst coverage

—

Blended fair value₹584

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Strong returns on equity (72%)
Capital is working hard (ROCE 90%)
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

43.8Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

71.6%Strong

Above 15% is considered healthy for Indian equities

ROCE

90.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.07Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹10,514 Cr

P/B

27.04

EPS

₹104.25

Div Yield

1.66%

What changed

Recent changes

Domestic institutions+0.2% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 43.8×

Growth

Steady

+7% rev CAGR

Profitability

Excellent

71.6% ROE

Financial health

Rock solid

D/E 0.07

Momentum

N/A

No technicals

Today

Trading activity

Delivery %43.8%

Turnover₹99.29L Cr

Trades806

VWAP₹4560.89

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+7.4%

—

10Y

—

Profit

+9.9%

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Company is almost debt free.
Company is expected to give good quarter
Company has a good return on equity (ROE) track record: 3 Years ROE 77.6%
Company has been maintaining a healthy dividend payout of 49.3%

Watch-outs

Cons

Stock is trading at 27.4 times its book value

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Domestic institutions added 0.24 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

71%

Promoter

Promoters

71.3%0.00

Public

6.3%+0.01

FII / FPI

2.8%-0.07

DII

17.6%+0.24

Others

2.1%

Total shareholders

48,418+343 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter71.27%

FII2.76%

DII17.57%

Public6.26%

Others2.14%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions